The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events
- 23 July 2008
- journal article
- research article
- Published by Springer Nature in Heart and Vessels
- Vol. 23 (4) , 243-248
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Expression of interferon-g and interleukin-4 production in CD4+ T cells in patients with chronic heart failureHeart and Vessels, 2007
- Predominant Effect of A-Type Natriuretic Peptide on Reduction of Oxidative Stress During the Treatment of Patients With Heart FailureCirculation Journal, 2007
- Anemia in Chronic Heart FailureCirculation, 2006
- The Interaction between Heart Failure, Renal Failure and Anemia – The Cardio-Renal Anemia SyndromeBlood Purification, 2004
- Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational studyThe Lancet, 2003
- Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failureJACC, 2002
- Decreased hematopoiesis in bone marrow of mice with congestive heart failureAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2002
- Evidence of Improving Prognosis in Heart FailureCirculation, 2000
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994
- Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.Circulation, 1991